COR-803

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCOR-803
Drug Alias NameCOR-803
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSARS-CoV-2-3C-like-proteinase inhibitors
TargetsSARS-CoV-2-3C-like-proteinase
Therapy Area/IndicationsCoronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQuince Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLighthouse Pharmaceuticals IncQuince Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A